Yeleswaram Krishnaswamy: insider trades.
Yeleswaram Krishnaswamy reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.6M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Yeleswaram Krishnaswamy
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Officer · Chief Development Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-25 | Rapport Therapeutics, Inc. | S | 16,201 | $51.06 | 195,862 | Form 4 |
| 2026-08-25 | Rapport Therapeutics, Inc. | S | 20,799 | $50.31 | 212,063 | Form 4 |
| 2026-08-24 | Rapport Therapeutics, Inc. | S | 13,160 | $50 | 232,862 | Form 4 |
| 2026-08-19 | Rapport Therapeutics, Inc. | S | 404 | $49.9 | 246,022 | Form 4 |
Questions
What stock did Yeleswaram Krishnaswamy buy or sell?
Yeleswaram Krishnaswamy reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($2.6M), across 1 company.
Is Yeleswaram Krishnaswamy the same person as other filers with this name?
This page covers SEC CIK 2022156 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/yeleswaram-krishnaswamy-2022156.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.